Beam Therapeutics Inc.
BEAM·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$25.70
Today
+4.5%
YTD
-7.1%
About
Beam Therapeutics, established in 2017, is a biotechnology company specialising in base-edited genetic therapeutics for serious diseases. The company operates across the US and has its headquarters in Cambridge, Massachusetts. Beam Therapeutics stock is listed on the NASDAQ GS where it has been trading under the BEAM ticker since Feb 2020. Diversify your eToro portfolio and invest in BEAM stock.
Price chart
Closing price history for BEAM (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-29.85
P/S (TTM)17.16
P/B (TTM)2.48
Market cap$2.65B
Cap tierMid-cap
Industry avg P/E-2.16
Profitability
Gross margin85.74%
EBIT margin-242.27%
Net margin-25036.33%
ROE-8.08%
ROA-6.15%
Earnings & Revenue
Revenue (TTM)$156.03M
Revenue growth (1Y)+158.9%
EPS (TTM)-$0.86
Free cash flow$-372.77M
Total debt$247.36M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)2.01
Employees511
Next earnings3 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.